ARMP
Price
$5.98
Change
+$0.28 (+4.91%)
Updated
Jan 15, 11:05 AM (EDT)
Capitalization
207.52M
63 days until earnings call
Intraday BUY SELL Signals
DSGN
Price
$9.16
Change
-$0.64 (-6.53%)
Updated
Jan 15, 11:22 AM (EDT)
Capitalization
558.24M
61 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ARMP vs DSGN

Header iconARMP vs DSGN Comparison
Open Charts ARMP vs DSGNBanner chart's image
Armata Pharmaceuticals
Price$5.98
Change+$0.28 (+4.91%)
Volume$200
Capitalization207.52M
Design Therapeutics
Price$9.16
Change-$0.64 (-6.53%)
Volume$100
Capitalization558.24M
ARMP vs DSGN Comparison Chart in %
ARMP
Daily Signal:
Gain/Loss:
DSGN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ARMP vs. DSGN commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARMP is a Hold and DSGN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (ARMP: $5.70 vs. DSGN: $9.80)
Brand notoriety: ARMP and DSGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARMP: 108% vs. DSGN: 27%
Market capitalization -- ARMP: $207.52M vs. DSGN: $558.24M
ARMP [@Biotechnology] is valued at $207.52M. DSGN’s [@Biotechnology] market capitalization is $558.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARMP’s FA Score shows that 0 FA rating(s) are green whileDSGN’s FA Score has 0 green FA rating(s).

  • ARMP’s FA Score: 0 green, 5 red.
  • DSGN’s FA Score: 0 green, 5 red.
According to our system of comparison, ARMP is a better buy in the long-term than DSGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARMP’s TA Score shows that 2 TA indicator(s) are bullish while DSGN’s TA Score has 2 bullish TA indicator(s).

  • ARMP’s TA Score: 2 bullish, 7 bearish.
  • DSGN’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, DSGN is a better buy in the short-term than ARMP.

Price Growth

ARMP (@Biotechnology) experienced а -14.67% price change this week, while DSGN (@Biotechnology) price change was -0.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

ARMP is expected to report earnings on Mar 19, 2026.

DSGN is expected to report earnings on Mar 17, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DSGN($558M) has a higher market cap than ARMP($208M). DSGN YTD gains are higher at: 4.478 vs. ARMP (-9.236). ARMP has higher annual earnings (EBITDA): -30.37M vs. DSGN (-77.38M). DSGN has more cash in the bank: 206M vs. ARMP (14.8M). DSGN has less debt than ARMP: DSGN (1.74M) vs ARMP (178M). ARMP (0) and DSGN (0) have equivalent revenues.
ARMPDSGNARMP / DSGN
Capitalization208M558M37%
EBITDA-30.37M-77.38M39%
Gain YTD-9.2364.478-206%
P/E RatioN/AN/A-
Revenue00-
Total Cash14.8M206M7%
Total Debt178M1.74M10,212%
FUNDAMENTALS RATINGS
ARMP: Fundamental Ratings
ARMP
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
PROFIT vs RISK RATING
1..100
64
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
93
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARMPDSGN
RSI
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 4 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
87%
MACD
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 8 days ago
85%
Bullish Trend 1 day ago
89%
Declines
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 11 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
81%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
ARMP
Daily Signal:
Gain/Loss:
DSGN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PMDAX20.680.09
+0.44%
Principal Small-MidCap Dividend Inc A
OAYBX39.680.13
+0.33%
Oakmark Equity and Income Advisor
WHGIX13.200.03
+0.23%
Westwood Income Opportunity Instl
FHEAX15.01N/A
N/A
Fidelity Advisor Real Estate A
SUTCX3.88-0.01
-0.26%
AB Sustainable US Thematic C

ARMP and

Correlation & Price change

A.I.dvisor tells us that ARMP and SRRK have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARMP and SRRK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARMP
1D Price
Change %
ARMP100%
-10.24%
SRRK - ARMP
25%
Poorly correlated
+4.18%
RAPT - ARMP
24%
Poorly correlated
+1.97%
SLN - ARMP
24%
Poorly correlated
-0.68%
CTNM - ARMP
24%
Poorly correlated
+7.89%
DSGN - ARMP
24%
Poorly correlated
+2.40%
More

DSGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSGN has been loosely correlated with IDYA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if DSGN jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSGN
1D Price
Change %
DSGN100%
+2.40%
IDYA - DSGN
51%
Loosely correlated
+5.53%
DYN - DSGN
50%
Loosely correlated
+2.41%
SLDB - DSGN
49%
Loosely correlated
+12.60%
AURA - DSGN
48%
Loosely correlated
+3.95%
RGNX - DSGN
48%
Loosely correlated
-0.66%
More